Antimicrobial Peptides: a New Frontier in Antifungal Therapy

Invasive fungal infections in humans are generally associated with high mortality, making the choice of antifungal drug crucial for the outcome of the patient. The limited spectrum of antifungals available and the development of drug resistance represent the main concerns for the current antifungal treatments, requiring alternative strategies. Antimicrobial peptides (AMPs), expressed in several organisms and used as first-line defenses against microbial infections, have emerged as potential candidates for developing new antifungal therapies, characterized by negligible host toxicity and low resistance rates. ABSTRACT Invasive fungal infections in humans are generally associated with high mortality, making the choice of antifungal drug crucial for the outcome of the patient. The limited spectrum of antifungals available and the development of drug resistance represent the main concerns for the current antifungal treatments, requiring alternative strategies. Antimicrobial peptides (AMPs), expressed in several organisms and used as first-line defenses against microbial infections, have emerged as potential candidates for developing new antifungal therapies, characterized by negligible host toxicity and low resistance rates. Most of the current literature focuses on peptides with antibacterial activity, but there are fewer studies of their antifungal properties. This review focuses on AMPs with antifungal effects, including their in vitro and in vivo activities, with the biological repercussions on the fungal cells, when known. The classification of the peptides is based on their mode of action: although the majority of AMPs exert their activity through the interaction with membranes, other mechanisms have been identified, including cell wall inhibition and nucleic acid binding. In addition, antifungal compounds with unknown modes of action are also described. The elucidation of such mechanisms can be useful to identify novel drug targets and, possibly, to serve as the templates for the synthesis of new antimicrobial compounds with increased activity and reduced host toxicity.

[1]  Ding Xu,et al.  Zinc Binding by Histatin 5 Promotes Fungicidal Membrane Disruption in C. albicans and C. glabrata , 2020, Journal of fungi.

[2]  E. Longhi,et al.  Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model , 2020, Scientific Reports.

[3]  I. Silva-Pereira,et al.  Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells , 2020, Scientific Reports.

[4]  Paul D. Cotter,et al.  Antifungal Peptides as Therapeutic Agents , 2020, Frontiers in Cellular and Infection Microbiology.

[5]  Zhiliang Yu,et al.  Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria , 2020, Applied Microbiology and Biotechnology.

[6]  D. Becher,et al.  Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37 , 2020, Microorganisms.

[7]  P. Johnston,et al.  Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC , 2020, Frontiers in Microbiology.

[8]  L. Larson,et al.  Hope on the Horizon: Novel Fungal Treatments in Development , 2020, Open forum infectious diseases.

[9]  Tuo-Hung Hou,et al.  SLIM: Simultaneous Logic-in-Memory Computing Exploiting Bilayer Analog OxRAM Devices , 2018, Scientific Reports.

[10]  G. Chinea,et al.  Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity , 2019, ACS omega.

[11]  Zhaoxin Lu,et al.  C16-Fengycin A affect the growth of Candida albicans by destroying its cell wall and accumulating reactive oxygen species , 2019, Applied Microbiology and Biotechnology.

[12]  L. Majoros,et al.  Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms , 2019, Letters in applied microbiology.

[13]  M. F. Fernandes-Pedrosa,et al.  Biodegradable cross-linked chitosan nanoparticles improve anti-Candida and anti-biofilm activity of TistH, a peptide identified in the venom gland of the Tityus stigmurus scorpion. , 2019, Materials science & engineering. C, Materials for biological applications.

[14]  H. Osada Discovery and applications of nucleoside antibiotics beyond polyoxin , 2019, The Journal of Antibiotics.

[15]  Larry R. Smith,et al.  First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults , 2019, Antimicrobial Agents and Chemotherapy.

[16]  Larry R. Smith,et al.  The Siderophore Transporter Sit1 Determines Susceptibility to the Antifungal VL-2397 , 2019, Antimicrobial Agents and Chemotherapy.

[17]  Kiyomitsu Katsumata,et al.  ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter , 2019, Antimicrobial Agents and Chemotherapy.

[18]  P. Permi,et al.  Characterization of the interaction of the antifungal and cytotoxic cyclic glycolipopeptide hassallidin with sterol-containing lipid membranes. , 2019, Biochimica et biophysica acta. Biomembranes.

[19]  M. Aida,et al.  Molecular Basis of Mannose Recognition by Pradimicins and their Application to Microbial Cell Surface Imaging. , 2019, Cell chemical biology.

[20]  M. Lorenz,et al.  Antifungal Activity of the Enterococcus faecalis Peptide EntV Requires Protease Cleavage and Disulfide Bond Formation , 2019, mBio.

[21]  C. L. Telzrow,et al.  Roles for Stress Response and Cell Wall Biosynthesis Pathways in Caspofungin Tolerance in Cryptococcus neoformans , 2019, Genetics.

[22]  H. Rahimi,et al.  Antifungal effects of indolicidin-conjugated gold nanoparticles against fluconazole-resistant strains of Candida albicans isolated from patients with burn infection , 2019, International journal of nanomedicine.

[23]  C. Bernard,et al.  Natural Products from Cyanobacteria: Focus on Beneficial Activities , 2019, Marine drugs.

[24]  Muhammad Arif,et al.  Plant defensins: types, mechanism of action and prospects of genetic engineering for enhanced disease resistance in plants , 2019, 3 Biotech.

[25]  Junling Shi,et al.  Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo , 2019, Applied Microbiology and Biotechnology.

[26]  N. Matsumori,et al.  The Perpendicular Orientation of Amphotericin B Methyl Ester in Hydrated Lipid Bilayers Supports the Barrel-Stave Model. , 2019, Biochemistry.

[27]  Ronald N. Jones,et al.  Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 , 2019, Open forum infectious diseases.

[28]  Balasubramanian Velramar,et al.  Investigation of antifungal activity of surfactin against mycotoxigenic phytopathogenic fungus Fusarium moniliforme and its impact in seed germination and mycotoxicosis. , 2019, Pesticide biochemistry and physiology.

[29]  C. Quan,et al.  Fungi-derived lipopeptide antibiotics developed since 2000 , 2019, Peptides.

[30]  W. Melchers,et al.  Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  P. Contursi,et al.  Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates , 2018, Scientific Reports.

[32]  S. Ōmura,et al.  Pestiocandin, a new papulacandin class antibiotic isolated from Pestalotiopsis humus , 2018, The Journal of Antibiotics.

[33]  T. Lu,et al.  Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform. , 2018, ACS synthetic biology.

[34]  M. Khoobi,et al.  Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis. , 2018, Journal de mycologie medicale.

[35]  Qian Yang,et al.  Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses , 2018, Journal of Virology.

[36]  M. Rouabhia,et al.  Dermaseptin‐S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes , 2018, Journal of applied microbiology.

[37]  Irina S Druzhinina,et al.  Hyporientalin A, an anti-Candida peptaibol from a marine Trichoderma orientale , 2018, World Journal of Microbiology and Biotechnology.

[38]  M. Fisher,et al.  Worldwide emergence of resistance to antifungal drugs challenges human health and food security , 2018, Science.

[39]  J. Schröder,et al.  Psoriasin, a novel anti-Candida albicans adhesin , 2018, Journal of Molecular Medicine.

[40]  Jinghua Li,et al.  Actinobacteria–Derived peptide antibiotics since 2000 , 2018, Peptides.

[41]  T. Lu,et al.  In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design , 2018, Nature Communications.

[42]  M. Selsted,et al.  Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species , 2018, Antimicrobial Agents and Chemotherapy.

[43]  Guozhi Yu,et al.  Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics , 2017, bioRxiv.

[44]  Kwan-Kyu Park,et al.  Antifungal Effects of Bee Venom Components on Trichophyton rubrum: A Novel Approach of Bee Venom Study for Possible Emerging Antifungal Agent , 2018, Annals of dermatology.

[45]  M. Tani,et al.  Overexpression of PDR16 confers resistance to complex sphingolipid biosynthesis inhibitor aureobasidin A in yeast Saccharomyces cerevisiae , 2018, FEMS microbiology letters.

[46]  B. Rathod,et al.  Novel actinomycin group compound from newly isolated Streptomyces sp. RAB12: isolation, characterization, and evaluation of antimicrobial potential , 2018, Applied Microbiology and Biotechnology.

[47]  Joseph Heitman,et al.  The Fungal Kingdom , 2017 .

[48]  T. Lazaridis,et al.  Transmembrane Pore Structures of β-Hairpin Antimicrobial Peptides by All-Atom Simulations. , 2017, The journal of physical chemistry. B.

[49]  J. Latgé,et al.  The Fungal Cell Wall: Structure, Biosynthesis, and Function , 2017, Microbiology spectrum.

[50]  M. Pinedo,et al.  Antimicrobial activity and mechanism of action of a thionin‐like peptide from Capsicum annuum fruits and combinatorial treatment with fluconazole against Fusarium solani , 2017, Biopolymers.

[51]  M. Lorenz,et al.  Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans , 2017, Proceedings of the National Academy of Sciences.

[52]  K. Roelants,et al.  An orthologue of the host‐defense protein psoriasin (S100A7) is expressed in frog skin , 2017, Developmental and comparative immunology.

[53]  I. Kyriakidis,et al.  Clinical hepatotoxicity associated with antifungal agents , 2016, Expert opinion on drug safety.

[54]  B. Cammue,et al.  Antimicrobial Peptides as a Strategy to Combat Fungal Biofilms. , 2016, Current topics in medicinal chemistry.

[55]  A. Fujie,et al.  ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-347833 , 2016, The Journal of Antibiotics.

[56]  Yoonkyung Park,et al.  The therapeutic applications of antimicrobial peptides (AMPs): a patent review , 2017, Journal of Microbiology.

[57]  O. Franco,et al.  Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms , 2016, Front. Microbiol..

[58]  V. Balcão,et al.  Alternatives to overcoming bacterial resistances: State-of-the-art. , 2016, Microbiological research.

[59]  M. F. Fernandes-Pedrosa,et al.  Characterization of TistH, a multifunctional peptide from the scorpion Tityus stigmurus: Structure, cytotoxicity and antimicrobial activity. , 2016, Toxicon : official journal of the International Society on Toxinology.

[60]  D. G. Lee,et al.  Cecropin A‐induced apoptosis is regulated by ion balance and glutathione antioxidant system in Candida albicans , 2016, IUBMB life.

[61]  N. Caroff,et al.  Identification and Biological Activities of Long‐Chain Peptaibols Produced by a Marine‐Derived Strain of Trichoderma longibrachiatum , 2016, Chemistry & biodiversity.

[62]  Lingaraja Jena,et al.  Computational Approach in Understanding Mechanism of Action of Isoniazidand Drug Resistance , 2016 .

[63]  T. Chiller,et al.  The Global Burden of Fungal Diseases. , 2016, Infectious disease clinics of North America.

[64]  J. Frisvad,et al.  Aspergillus mulundensis sp. nov., a new species for the fungus producing the antifungal echinocandin lipopeptides, mulundocandins , 2015, The Journal of Antibiotics.

[65]  M. da Cunha,et al.  Thionin-like peptide from Capsicum annuum fruits: mechanism of action and synergism with fluconazole against Candida species , 2016, BMC Microbiology.

[66]  Roland R. Regoes,et al.  Combination Effects of Antimicrobial Peptides , 2016, Antimicrobial Agents and Chemotherapy.

[67]  D. Stevens,et al.  Mycologic Endocrinology. , 2016, Advances in experimental medicine and biology.

[68]  J. Grötzinger,et al.  Disulphide-reduced psoriasin is a human apoptosis-inducing broad-spectrum fungicide , 2015, Proceedings of the National Academy of Sciences.

[69]  C. León-Ramírez,et al.  In vitro effect of recombinant amaranth cystatin (AhCPI) on spore germination, mycelial growth, stress response and cellular integrity of Aspergillus niger and Aspergillus parasiticus , 2015, Mycology.

[70]  Stefania Galdiero,et al.  The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules , 2015, Microbial Cell Factories.

[71]  N. Gow,et al.  Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies , 2015, Antimicrobial Agents and Chemotherapy.

[72]  Xiaowei Zhan,et al.  Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization , 2015, Nature Medicine.

[73]  M. Starnbach,et al.  Cm‐p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae) , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  Mingwen Zhao,et al.  The bacterial lipopeptide iturins induce Verticillium dahliae cell death by affecting fungal signalling pathways and mediate plant defence responses involved in pathogen-associated molecular pattern-triggered immunity. , 2015, Environmental microbiology.

[75]  Lingaraja Jena,et al.  Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug. , 2014, International journal of mycobacteriology.

[76]  G. Bills,et al.  New insights into the echinocandins and other fungal non-ribosomal peptides and peptaibiotics. , 2014, Natural product reports.

[77]  J. Argüelles,et al.  The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug , 2014, Antimicrobial Agents and Chemotherapy.

[78]  J. Ernst,et al.  Interplay between Candida albicans and the Antimicrobial Peptide Armory , 2014, Eukaryotic Cell.

[79]  M. Edgerton,et al.  How Does It Kill?: Understanding the Candidacidal Mechanism of Salivary Histatin 5 , 2014, Eukaryotic Cell.

[80]  Juneyoung Lee,et al.  Melittin triggers apoptosis in Candida albicans through the reactive oxygen species-mediated mitochondria/caspase-dependent pathway. , 2014, FEMS microbiology letters.

[81]  P. Permi,et al.  Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway , 2014, Proceedings of the National Academy of Sciences.

[82]  Andrew J. Nieuwkoop,et al.  Amphotericin forms an extramembranous and fungicidal sterol sponge , 2014, Nature chemical biology.

[83]  Anil Kumar Singh,et al.  Lipopeptides from Bacillus strain AR2 inhibits biofilm formation by Candida albicans , 2014, Antonie van Leeuwenhoek.

[84]  N. Gow,et al.  Modulation of Alternaria infectoria Cell Wall Chitin and Glucan Synthesis by Cell Wall Synthase Inhibitors , 2014, Antimicrobial Agents and Chemotherapy.

[85]  M. Motyl,et al.  Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates , 2013, Antimicrobial Agents and Chemotherapy.

[86]  N. Gow,et al.  Mannosylation in Candida albicans: role in cell wall function and immune recognition , 2013, Molecular microbiology.

[87]  M. Ueda,et al.  Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics , 2013, Pharmaceuticals.

[88]  Z. Chi,et al.  Antifungal activity of the lipopeptides produced by Bacillus amyloliquefaciens anti-CA against Candida albicans isolated from clinic , 2013, Applied Microbiology and Biotechnology.

[89]  Marilyn A. Anderson,et al.  Identification and Mechanism of Action of the Plant Defensin NaD1 as a New Member of the Antifungal Drug Arsenal against Candida albicans , 2013, Antimicrobial Agents and Chemotherapy.

[90]  E. Novellino,et al.  Novel α-MSH Peptide Analogues with Broad Spectrum Antimicrobial Activity , 2013, PloS one.

[91]  Ronald N. Jones,et al.  Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST). , 2013, The Journal of antimicrobial chemotherapy.

[92]  S. Tay,et al.  The inhibitory effects of aureobasidin A on Candida planktonic and biofilm cells , 2013, Mycoses.

[93]  F. Tangy,et al.  In vitro antiviral activity of dermaseptin S4 and derivatives from amphibian skin against herpes simplex virus type 2 , 2013, Journal of medical virology.

[94]  C. Stenland,et al.  A practical and scalable manufacturing process for an anti-fungal agent, Nikkomycin Z. , 2013, Organic process research & development.

[95]  T. Calandra,et al.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[96]  M. Bassetti,et al.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[97]  N. Gow,et al.  Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin , 2012, Antimicrobial Agents and Chemotherapy.

[98]  P. Fritz,et al.  Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin. , 2012, Medical mycology.

[99]  Lixin Zhang,et al.  Optimization for the Production of Surfactin with a New Synergistic Antifungal Activity , 2012, PloS one.

[100]  O. Franco,et al.  Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus. , 2012, Biochimie.

[101]  Daniel S. Palacios,et al.  Amphotericin primarily kills yeast by simply binding ergosterol , 2012, Proceedings of the National Academy of Sciences.

[102]  Guangshun Wang Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering. , 2011, Current biotechnology.

[103]  N. Gow,et al.  Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo , 2011, Antimicrobial Agents and Chemotherapy.

[104]  D. Bierer,et al.  New β-glucan inhibitors as antifungal drugs , 2011, Expert opinion on therapeutic patents.

[105]  H. Vogel,et al.  The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.

[106]  Robert E. W. Hancock,et al.  Multifunctional cationic host defence peptides and their clinical applications , 2011, Cellular and Molecular Life Sciences.

[107]  C. Lan,et al.  Human Antimicrobial Peptide LL-37 Inhibits Adhesion of Candida albicans by Interacting with Yeast Cell-Wall Carbohydrates , 2011, PloS one.

[108]  Zhaoxin Lu,et al.  Antifungal activity and mechanism of fengycin in the presence and absence of commercial surfactin against Rhizopus stolonifer , 2011, The Journal of Microbiology.

[109]  M. Busman,et al.  Fusarium verticillioides chitin synthases CHS5 and CHS7 are required for normal growth and pathogenicity , 2011, Current Genetics.

[110]  C. Santa-Catarina,et al.  Antifungal Activity of PvD1 Defensin Involves Plasma Membrane Permeabilization, Inhibition of Medium Acidification, and Induction of ROS in Fungi Cells , 2011, Current Microbiology.

[111]  Ivone M. Martins,et al.  Differential Activities of Three Families of Specific β(1,3)Glucan Synthase Inhibitors in Wild-type and Resistant Strains of Fission Yeast* , 2010, The Journal of Biological Chemistry.

[112]  Giulio Superti-Furga,et al.  A Computational Approach to Analyze the Mechanism of Action of the Kinase Inhibitor Bafetinib , 2010, PLoS Comput. Biol..

[113]  N. Gow,et al.  Chitin synthesis and fungal pathogenesis , 2010, Current opinion in microbiology.

[114]  M. Edgerton,et al.  Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans , 2010, Molecular microbiology.

[115]  D. G. Lee,et al.  Melittin induces apoptotic features in Candida albicans. , 2010, Biochemical and biophysical research communications.

[116]  Georg E. Fantner,et al.  Kinetics of Antimicrobial Peptide Activity Measured on Individual Bacterial Cells Using High Speed AFM , 2010, Nature nanotechnology.

[117]  M. Kawada,et al.  Leucinostatin A inhibits prostate cancer growth through reduction of insulin‐like growth factor‐I expression in prostate stromal cells , 2009, International journal of cancer.

[118]  M. Kołaczkowski,et al.  The antifungal properties of chicken egg cystatin against Candida yeast isolates showing different levels of azole resistance , 2009, Mycoses.

[119]  Helgi I. Ingólfsson,et al.  Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes , 2010, Journal of The Royal Society Interface.

[120]  Ju Hyun Cho,et al.  Buforins: histone H2A-derived antimicrobial peptides from toad stomach. , 2009, Biochimica et biophysica acta.

[121]  S. Ōmura,et al.  In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin , 2009, The Journal of Antibiotics.

[122]  M. Leippe,et al.  Antimicrobial activity of bovine psoriasin. , 2009, Veterinary microbiology.

[123]  J. Galgiani,et al.  Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses , 2009, Antimicrobial Agents and Chemotherapy.

[124]  B. Kofler,et al.  Anti‐Candida activity of α‐melanocyte‐stimulating hormone (α‐MSH) peptides , 2009, Journal of leukocyte biology.

[125]  P. Aeed,et al.  Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A , 2009, Antimicrobial Agents and Chemotherapy.

[126]  Seong-Cheol Park,et al.  Pr-1, a novel antifungal protein from pumpkin rinds , 2009, Biotechnology Letters.

[127]  M. Cunha,et al.  Isolation, characterization and cloning of a cDNA encoding a new antifungal defensin from Phaseolus vulgaris L. seeds , 2008, Peptides.

[128]  R. Nagaraj,et al.  Antifungal Activities of Human Beta-Defensins HBD-1 to HBD-3 and Their C-Terminal Analogs Phd1 to Phd3 , 2008, Antimicrobial Agents and Chemotherapy.

[129]  D. Elmore,et al.  Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II , 2008, FEBS letters.

[130]  Seong-Cheol Park,et al.  Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. , 2008, Biochimica et biophysica acta.

[131]  Alistair J. P. Brown,et al.  Immune Recognition of Candida albicans β-glucan by Dectin-1 , 2007 .

[132]  S. Vylkova,et al.  Histatin 5 Initiates Osmotic Stress Response in Candida albicans via Activation of the Hog1 Mitogen-Activated Protein Kinase Pathway , 2007, Eukaryotic Cell.

[133]  D. Perlin Resistance to echinocandin-class antifungal drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[134]  Xilin Zhao,et al.  Mutant selection window hypothesis updated. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[135]  E. Graziani,et al.  Septocylindrins A and B: peptaibols produced by the terrestrial fungus Septocylindrium sp. LL-Z1518. , 2007, Journal of natural products.

[136]  Trees Jansen,et al.  Immune recognition of Candida albicans beta-glucan by dectin-1. , 2007, The Journal of infectious diseases.

[137]  H. Vogel,et al.  Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. , 2006, Biophysical journal.

[138]  M. Benincasa,et al.  Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. , 2006, The Journal of antimicrobial chemotherapy.

[139]  Y. Pommier,et al.  Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites , 2006, Nucleic acids research.

[140]  E. Zmuda,et al.  Antimicrobial Activities and Structures of Two Linear Cationic Peptide Families with Various Amphipathic β-Sheet and α-Helical Potentials , 2005, Antimicrobial Agents and Chemotherapy.

[141]  C. Vágvölgyi,et al.  Peptaibols and related peptaibiotics of Trichoderma. A review. , 2005, Acta microbiologica et immunologica Hungarica.

[142]  A. Ortiz,et al.  Further aspects on the hemolytic activity of the antibiotic lipopeptide iturin A. , 2005, Biochimica et biophysica acta.

[143]  L. Sijtsma,et al.  Antifungal activity of synthetic peptides derived from Impatiens balsamina antimicrobial peptides Ib-AMP1 and Ib-AMP4 , 2005, Peptides.

[144]  Suzanne M Johnson,et al.  Comparison of susceptibility of fungal isolates to lufenuron and nikkomycin Z alone or in combination with itraconazole. , 2005, American journal of veterinary research.

[145]  J. van Marle,et al.  Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. , 2005, The Biochemical journal.

[146]  J. Schröder,et al.  Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins , 2005, Journal of leukocyte biology.

[147]  K. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[148]  M. Ferguson,et al.  Mnt1p and Mnt2p of Candida albicans Are Partially Redundant α-1,2-Mannosyltransferases That Participate in O-Linked Mannosylation and Are Required for Adhesion and Virulence* , 2005, Journal of Biological Chemistry.

[149]  J. Ernst,et al.  PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance , 2004, Molecular microbiology.

[150]  K. Fuji,et al.  New antibiotics, trichopolyns A and B: Isolation and biological activity , 1978, Experientia.

[151]  J. Schröder,et al.  Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection , 2005, Nature Immunology.

[152]  K. Hahm,et al.  Effects of N- and C-terminal truncation of HP (2-20) from Helicobacter pylori ribosomal protein L1 (RPL1) on its anti-microbial activity , 2005, Biotechnology Letters.

[153]  C. Slayman,et al.  The TRK1 Potassium Transporter Is the Critical Effector for Killing of Candida albicans by the Cationic Protein, Histatin 5* , 2004, Journal of Biological Chemistry.

[154]  G. Alangaden,et al.  In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[155]  B. Thomma,et al.  Defensins from Insects and Plants Interact with Fungal Glucosylceramides* , 2004, Journal of Biological Chemistry.

[156]  K. Hahm,et al.  Antifungal mechanism of a cysteine-rich antimicrobial peptide, Ib-AMP1, from Impatiens balsamina against Candida albicans , 1999, Biotechnology Letters.

[157]  J. Bland,et al.  Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis , 1991, Mycopathologia.

[158]  E. Medina-Acosta,et al.  Prevention of lethal murine candidiasis using HP (2–20), an antimicrobial peptide derived from the N-terminus of Helicobacter pylori ribosomal protein L1 , 2003, Peptides.

[159]  Y. Igarashi,et al.  Apoptosis-like cell death of Saccharomyces cerevisiae induced by a mannose-binding antifungal antibiotic, pradimicin. , 2003, The Journal of antibiotics.

[160]  M. Papagianni Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. , 2003, Biotechnology advances.

[161]  M. Edgerton,et al.  Candida albicans Ssa1/2p Is the Cell Envelope Binding Protein for Human Salivary Histatin 5* , 2003, Journal of Biological Chemistry.

[162]  Seong-Cheol Park,et al.  Fungicidal effect of indolicidin and its interaction with phospholipid membranes. , 2003, Biochemical and Biophysical Research Communications - BBRC.

[163]  A. Ramamoorthy,et al.  MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. , 2003, Biophysical journal.

[164]  Robert Finking,et al.  Biosynthesis of nonribosomal peptides , 2003 .

[165]  D. Stevens,et al.  Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model. , 2002, The Journal of antimicrobial chemotherapy.

[166]  T. Hosoya,et al.  F-10748 A1, A2, B1, B2, C1, C2, D1 and D2, novel papulacandins. , 2002, The Journal of antibiotics.

[167]  D. Barrett From natural products to clinically useful antifungals. , 2002, Biochimica et biophysica acta.

[168]  I. Yoo,et al.  Atroviridins A-C and neoatroviridins A-D, novel peptaibol antibiotics produced by Trichoderma atroviride F80317. I. Taxonomy, fermentation, isolation and biological activities. , 2002, The Journal of antibiotics.

[169]  W. Gerwick,et al.  Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. , 2002, Journal of natural products.

[170]  Hee-Moon Park,et al.  Inhibitory effect of nikkomycin Z on chitin synthases in Candida albicans , 2002, Yeast.

[171]  K. Hahm,et al.  Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans. , 2002, Biochemical and biophysical research communications.

[172]  T. Walsh,et al.  Synergy, Pharmacodynamics, and Time-Sequenced Ultrastructural Changes of the Interaction between Nikkomycin Z and the Echinocandin FK463 against Aspergillus fumigatus , 2001, Antimicrobial Agents and Chemotherapy.

[173]  F. Oppenheim,et al.  The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[174]  R. Hancock,et al.  Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.

[175]  Chris D. Clark,et al.  Spectrographic imaging: A bird's-eye view of the health of coral reefs , 2001, Nature.

[176]  S. Gordon,et al.  Immune recognition: A new receptor for β-glucans , 2001, Nature.

[177]  L. Yang,et al.  Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.

[178]  H. Nikawa,et al.  Antifungal activity of histatin-5 against non-albicans Candida species. , 2001, Oral microbiology and immunology.

[179]  B. Wallace,et al.  Peptaibols: models for ion channels. , 2001, Biochemical Society transactions.

[180]  E. Anaissie,et al.  Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[181]  I. Algarra,et al.  The use of 7-amino-actinomycin D in the analysis of Candida albicans phagocytosis and opsonization. , 2001, Journal of immunological methods.

[182]  A. Espinel-Ingroff In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi , 2001, Journal of Clinical Microbiology.

[183]  C. Douglas Fungal β(1,3)-d-glucan synthesis , 2001 .

[184]  C. Douglas Fungal beta(1,3)-D-glucan synthesis. , 2001, Medical mycology.

[185]  J. Bruenn,et al.  Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways , 2000, Antimicrobial Agents and Chemotherapy.

[186]  D. Ishiyama,et al.  Heptaibin, a novel antifungal peptaibol antibiotic from Emericellopsis sp. BAUA8289. , 2000, The Journal of antibiotics.

[187]  C. B. Park,et al.  Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[188]  J. Ernst,et al.  Morphogenesis, Adhesive Properties, and Antifungal Resistance Depend on the Pmt6 Protein Mannosyltransferase in the Fungal Pathogen Candida albicans , 2000, Journal of bacteriology.

[189]  E. Brizendine,et al.  Comparison of Nikkomycin Z with Amphotericin B and Itraconazole for Treatment of Histoplasmosis in a Murine Model , 2000, Antimicrobial Agents and Chemotherapy.

[190]  Wenyan Zhong,et al.  Inhibition of Inositol Phosphorylceramide Synthase by Aureobasidin A in Candida and AspergillusSpecies , 2000, Antimicrobial Agents and Chemotherapy.

[191]  J. M. Lipton,et al.  Antimicrobial effects of α‐MSH peptides , 2000 .

[192]  J. A. Radding,et al.  Inositol phosphoryl transferases from human pathogenic fungi. , 2000, Biochimica et biophysica acta.

[193]  S. Blondelle,et al.  Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. , 2000, Biopolymers.

[194]  B. Bechinger,et al.  The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. , 1999, Biochimica et biophysica acta.

[195]  H. Vogel,et al.  Diversity of antimicrobial peptides and their mechanisms of action. , 1999, Biochimica et biophysica acta.

[196]  Franky R. G. Terras,et al.  Permeabilization of Fungal Membranes by Plant Defensins Inhibits Fungal Growth , 1999, Applied and Environmental Microbiology.

[197]  F. Barchiesi,et al.  In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. , 1999, The Journal of antimicrobial chemotherapy.

[198]  G. K. Johnson,et al.  Production of β-Defensin Antimicrobial Peptides by the Oral Mucosa and Salivary Glands , 1999, Infection and Immunity.

[199]  S. Hawser,et al.  Mulundocandin, an echinocandin-like lipopeptide antifungal agent: biological activities in vitro. , 1999, The Journal of antibiotics.

[200]  T. Walsh,et al.  Antifungal Peptides: Novel Therapeutic Compounds against Emerging Pathogens , 1999, Antimicrobial Agents and Chemotherapy.

[201]  C. Potvin,et al.  Several Thaumatin-Like Proteins Bind to β-1,3-Glucans , 1998 .

[202]  Alan J. Waring,et al.  Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.

[203]  C. B. Park,et al.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.

[204]  C. Subbalakshmi,et al.  Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.

[205]  S. Y. Lee,et al.  Two hevein homologs isolated from the seed of Pharbitis nil L. exhibit potent antifungal activity. , 1998, Biochimica et biophysica acta.

[206]  H. Yamaguchi,et al.  Mode of antifungal action of benanomicin A in Saccharomyces cerevisiae. , 1997, The Journal of antibiotics.

[207]  J. Smith,et al.  Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis , 1997, Antimicrobial agents and chemotherapy.

[208]  J. McAlpine,et al.  Corynecandin: a novel antifungal glycolipid from Coryneum modonium. , 1997, The Journal of antibiotics.

[209]  I. J. Evans,et al.  A Novel Family of Small Cysteine-rich Antimicrobial Peptides from Seed of Impatiens balsamina Is Derived from a Single Precursor Protein* , 1997, The Journal of Biological Chemistry.

[210]  D. Stevens,et al.  Efficacy of nikkomycin Z against experimental pulmonary blastomycosis , 1997, Antimicrobial agents and chemotherapy.

[211]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[212]  C. Kozak,et al.  Identification of CRAMP, a Cathelin-related Antimicrobial Peptide Expressed in the Embryonic and Adult Mouse* , 1997, The Journal of Biological Chemistry.

[213]  T. Cleveland,et al.  Fungicidal activity of cecropin A , 1997, Antimicrobial agents and chemotherapy.

[214]  E. Segal,et al.  Adhesion of Candida albicans to epithelial cells ‐ effect of nikkomycin , 1997, Mycoses.

[215]  J. M. Lipton,et al.  The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro , 1996, Peptides.

[216]  E. Veerman,et al.  Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin. , 1996, Biological chemistry.

[217]  J. Takemoto,et al.  In vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae , 1996, Antimicrobial agents and chemotherapy.

[218]  S. Deshmukh,et al.  Arthrichitin. A New Cell Wall Active Metabolite from Arthrinium phaeospermum. , 1996, The Journal of organic chemistry.

[219]  C. Brownlee,et al.  Fungal Membrane Responses Induced by Plant Defensins and Thionins* , 1996, The Journal of Biological Chemistry.

[220]  Y. Shai,et al.  Broad spectrum antibiotic activity of the skin-PYY. , 1996, FEBS letters.

[221]  J. M. Lipton,et al.  α‐MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line , 1996 .

[222]  E. Veerman,et al.  Cystatins in health and disease. , 1996, Biological chemistry Hoppe-Seyler.

[223]  J. M. Lipton,et al.  The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. , 1996, Peptides.

[224]  J. M. Lipton,et al.  Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[225]  M. Selsted,et al.  Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. , 1995, Biochimica et biophysica acta.

[226]  J. McAlpine,et al.  Fusacandins A and B; novel antifungal antibiotics of the papulacandin class from Fusarium sambucinum. II. Isolation and structural elucidation. , 1995, The Journal of antibiotics.

[227]  M. Tester,et al.  Role of biosurfactant and ion channel-forming activities of syringomycin in transmembrane ion flux: a model for the mechanism of action in the plant-pathogen interaction. , 1995, Molecular plant-microbe interactions : MPMI.

[228]  H. Shimizu,et al.  Successful treatment of Pneumocystis carinii Pneumonia in mice with benanomicin A (ME1451) , 1995, Antimicrobial agents and chemotherapy.

[229]  B. Schlegel,et al.  Helioferins; novel antifungal lipopeptides from Mycogone rosea: screening, isolation, structures and biological properties. , 1995, The Journal of antibiotics.

[230]  Y. Lim,et al.  Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. I. Taxonomy, production, isolation and biological activity. , 1994, The Journal of antibiotics.

[231]  H. Vaudry,et al.  Skin peptide tyrosine-tyrosine, a member of the pancreatic polypeptide family: isolation, structure, synthesis, and endocrine activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[232]  F. Odds,et al.  Molecular mechanisms of drug resistance in fungi. , 1994, Trends in microbiology.

[233]  M. Okuhara,et al.  WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties. , 1994, The Journal of antibiotics.

[234]  J. Johansson,et al.  Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide. , 1994, European journal of biochemistry.

[235]  F. Peypoux,et al.  Iturins, a special class of pore-forming lipopeptides: biological and physicochemical properties. , 1994, Toxicology.

[236]  A. Mor,et al.  Isolation and structure of novel defensive peptides from frog skin. , 1994, European journal of biochemistry.

[237]  M. Debono,et al.  Antibiotics that inhibit fungal cell wall development. , 1994, Annual review of microbiology.

[238]  M. Ghannoum,et al.  Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro , 1993, Antimicrobial Agents and Chemotherapy.

[239]  K. Takesako,et al.  Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic. , 1993, The Journal of antibiotics.

[240]  F. Trautinger,et al.  Production of Immunosuppressing Melanotropins By Human Keratinocytes a , 1993, Annals of the New York Academy of Sciences.

[241]  T. Oki,et al.  Studies on the mode of antifungal action of pradimicin antibiotics. I. Lectin-mimic binding of BMY-28864 to yeast mannan in the presence of calcium. , 1993, The Journal of antibiotics.

[242]  Y. Shai,et al.  Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. , 1992, Biochemistry.

[243]  J. L. Smith,et al.  Pneumocandins from Zalerion arboricola. III. Structure elucidation. , 1992, The Journal of antibiotics.

[244]  D. Schmatz,et al.  In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin , 1992, Antimicrobial Agents and Chemotherapy.

[245]  Wayne L. Smith,et al.  Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.

[246]  Y. Shai,et al.  Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. , 1991, The Journal of biological chemistry.

[247]  W. K. Roberts,et al.  A new family of plant antifungal proteins. , 1991, Molecular plant-microbe interactions : MPMI.

[248]  R. Calderone,et al.  Adherence and receptor relationships of Candida albicans. , 1991, Microbiological reviews.

[249]  M. Okuhara,et al.  FR900403, a new antifungal antibiotic produced by a Kernia sp. , 1990, The Journal of antibiotics.

[250]  T. Oki,et al.  New antifungal antibiotics, pradimicins D and E. Glycine analogs of pradimicins A and C. , 1990, The Journal of antibiotics.

[251]  T. Oki,et al.  Pradimicins A, B and C: new antifungal antibiotics. II. In vitro and in vivo biological activities. , 1990, The Journal of antibiotics.

[252]  B. Zimmer,et al.  Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis , 1990, Antimicrobial Agents and Chemotherapy.

[253]  K. Fukushima,et al.  Dual inhibitory effects of the peptide antibiotics leucinostatins on oxidative phosphorylation in mitochondria. , 1990, Cell structure and function.

[254]  T. F. Butler,et al.  Synthesis and Evaluation of LY121019, a Member of a Series of Semisynthetic Analogues of the Antifungal Lipopeptide Echinocandin B a , 1988 .

[255]  H. Kawaguchi,et al.  Pradimicin, a novel class of potent antifungal antibiotics. , 1988, The Journal of antibiotics.

[256]  H. Naganawa,et al.  New antifungal antibiotics, benanomicins A and B from an actinomycete. , 1988, The Journal of antibiotics.

[257]  T. Ganz,et al.  In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. , 1986, The Journal of infectious diseases.

[258]  F. Peypoux,et al.  Interactions of antibiotics of the iturin group with human erythrocytes. , 1986, Biochimica et biophysica acta.

[259]  T. Ganz,et al.  Activity of rabbit leukocyte peptides against Candida albicans , 1985, Infection and immunity.

[260]  M. Selsted,et al.  In vitro effect of phagocyte cationic peptides on Coccidioides immitis. , 1985, The Journal of infectious diseases.

[261]  M. Suzuki,et al.  Structure of leucinostatin B, an uncoupler on mitochondria. , 1983, The Journal of antibiotics.

[262]  J. Becker,et al.  Polyoxin D inhibits growth of zoopathogenic fungi , 1983, Antimicrobial Agents and Chemotherapy.

[263]  H. Yamaguchi,et al.  In vitro studies of aculeacin A, a new antifungal antibiotic. , 1982, The Journal of antibiotics.

[264]  P. Traxler,et al.  Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E. , 1977, The Journal of antibiotics.

[265]  A. Yagi,et al.  STUDIES ON ACULEACIN , 1977 .

[266]  A. Yagi,et al.  Studies on aculeacin. I. Isolation and characterization of aculeacin A. , 1977, The Journal of antibiotics.

[267]  F. Rumjanek,et al.  The peptide components of bee venom. , 1976, European journal of biochemistry.

[268]  K. Kakiki,et al.  STUDIES ON THE MODE OF ACTION OF POLYOXINS. VI , 1974 .

[269]  F. Benz,et al.  Stoffwechselprodukte von Mikroorganismen 143. Mitteilung. Echinocandin B, ein neuartiges Polypeptid‐Antibioticum aus Aspergillus nidulans var. echinulatus: Isolierung und Bausteine , 1974 .

[270]  F. Benz Echinocandin B. Ein neuartiges polypeptide-antibiotikum aus Aspergillus nidulans var. echinulatus : Isolierung und bausteine , 1974 .

[271]  K. Kakiki,et al.  Studies on the mode of action of polyoxins. VI. Effect of polyoxin B on chitin synthesis in polyoxin-sensitive and resistant strains of Alternaria kikuchiana. , 1974, The Journal of antibiotics.

[272]  K. Yazawa,et al.  A new antibiotic, leucinostatin, derived from Penicillium lilacinum. , 1973, The Journal of antibiotics.

[273]  K. Isono,et al.  Studies on polyoxins, antifungal antibiotics. 13. The structure of polyoxins. , 1969, Journal of the American Chemical Society.

[274]  M. R. Holmes,et al.  Cell wall composition of the mycelial and blastospore forms of Candida albicans. , 1968, Journal of general microbiology.

[275]  M. Landy,et al.  Bacillomycin; an antibiotic from Bacillus subtilis active against pathogenic fungi. , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[276]  R. Synge,et al.  The kinetics of low temperature acid hydrolysis of gramicidin and of some related dipeptides. , 1945, The Biochemical journal.

[277]  R. Dubos,et al.  STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS , 1939, The Journal of experimental medicine.

[278]  R. Dubos STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS , 1939, The Journal of experimental medicine.